Showing results (11-20 of 159) with videos related to
Sort By:
Pageof 16
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 28, 2010
Vesicular stomatitis virus-induced immune suppressor cells generate antagonism between intratumoral oncolytic virus and cyclophosphamideCandice Willmon, Rosa M Diaz, Phonphimon Wongthida, et al.Cancer Research|May 21, 2010
Type III IFN interleukin-28 mediates the antitumor efficacy of oncolytic virus VSV in immune-competent mouse models of cancerPhonphimon Wongthida, Rosa Maria Diaz, Feorillo Galivo, et al.Human Gene Therapy|March 4, 2011
Activating systemic T-cell immunity against self tumor antigens to support oncolytic virotherapy with vesicular stomatitis virusPhonphimon Wongthida, Rosa Maria Diaz, Christine Pulido, et al.Cancer Research|October 3, 2002
Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusionEmmanouela Linardakis, Andrew Bateman, Vy Phan, et al.Cancer Gene Therapy|March 24, 2026
The TCR in CAR T cell therapy: use it or lose it?Olivia Liseth, Richard VileJournal of Immunology (Baltimore, Md. : 1950)|April 22, 2008
Reovirus activates human dendritic cells to promote innate antitumor immunityFiona Errington, Lynette Steele, Robin Prestwich, et al.BMC Cancer|June 8, 2011
Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancerLucy Heinemann, Guy R Simpson, Angela Boxall, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|June 25, 2014
Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virusElizabeth Ilett, Timothy Kottke, Oliver Donnelly, et al.Journal for Immunotherapy of Cancer|July 24, 2021
Antiviral antibody responses to systemic administration of an oncolytic RNA virus: the impact of standard concomitant anticancer chemotherapiesVictoria Roulstone, David Mansfield, Robert J Harris, et al.Cancer Research|December 20, 2007
Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancerTimothy Kottke, Luis Sanchez-Perez, Rosa Maria Diaz, et al.Pageof 16